News | September 02, 2021
Granules India receive DRDO licence to manufacture and market 2-DG
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
Textiles treated with the technology have also been proven to deactivate viruses, including SARS-CoV-2 (the virus that causes COVID-19).
The company has to approach the DCGI for approval to commence the trials
This is the first of its kind vaccine for Covid 19 to get the go-ahead
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
_logo_256_384.jpg){kind=logo}
It supports sequencing-based COVID 19 surveillance in India
Five seats reserved for Wards of COVID warriors in central MBBS admission
Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)